451 related articles for article (PubMed ID: 28543170)
1. Specific activation of CD4
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
[TBL] [Abstract][Full Text] [Related]
2. Distinct CD4
Passos LSA; Koh CC; Magalhães LMD; Nunes MDCP; Gollob KJ; Dutra WO
Front Immunol; 2021; 12():761795. PubMed ID: 34868005
[TBL] [Abstract][Full Text] [Related]
3. Activation of Human CD11b
Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
Front Immunol; 2018; 9():3015. PubMed ID: 30662439
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease.
Villani FN; Rocha MO; Nunes Mdo C; Antonelli LR; Magalhães LM; dos Santos JS; Gollob KJ; Dutra WO
Infect Immun; 2010 Oct; 78(10):4421-30. PubMed ID: 20696836
[TBL] [Abstract][Full Text] [Related]
5. Blocking of CD1d Decreases Trypanosoma cruzi-Induced Activation of CD4-CD8- T Cells and Modulates the Inflammatory Response in Patients With Chagas Heart Disease.
Passos LS; Villani FN; Magalhães LM; Gollob KJ; Antonelli LR; Nunes MC; Dutra WO
J Infect Dis; 2016 Sep; 214(6):935-44. PubMed ID: 27368347
[TBL] [Abstract][Full Text] [Related]
6. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
[TBL] [Abstract][Full Text] [Related]
9. Blocking activation of CD4
Neves EGA; Koh CC; Lucinda PPD; Souza-Silva TG; Medeiros NI; Pantaleão A; Mutarelli A; Gomes JAS; Silva SA; Gollob KJ; Nunes MDCP; Dutra WO
Clin Immunol; 2023 Jun; 251():109331. PubMed ID: 37088297
[TBL] [Abstract][Full Text] [Related]
10. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
[TBL] [Abstract][Full Text] [Related]
11. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
[TBL] [Abstract][Full Text] [Related]
12. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
[TBL] [Abstract][Full Text] [Related]
13. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
[TBL] [Abstract][Full Text] [Related]
15. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
Damasio MPS; Rocha MOC; Sousa GR; Ferreira KS; Fares-Gusmão RCG; Medeiros NI; Araujo FF; Chaves AT; Dutra WO; Correa-Oliveira R; Gomes JAS
Hum Immunol; 2019 Jul; 80(7):517-522. PubMed ID: 30853363
[TBL] [Abstract][Full Text] [Related]
16. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764
[TBL] [Abstract][Full Text] [Related]
17. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
Gomes JA; Bahia-Oliveira LM; Rocha MO; Busek SC; Teixeira MM; Silva JS; Correa-Oliveira R
Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
[TBL] [Abstract][Full Text] [Related]
19. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
20. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
de Melo AS; de Lorena VM; de Moura Braz SC; Docena C; de Miranda Gomes Y
Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
